CClinicalTrials.gg
CompletedNCT04299100Updated Dec 10, 2021

Sleep Health Program for Patients With Chronic Pain

An interventional study of Sleep Health Program for Participants with No/Mild Sleep Apnea and Sleep Health Program for Participants with Moderate/Severe Sleep Apnea in Sleep Disordered Breathing, Chronic Pain and Sleep, sponsored by University Health Network, Toronto. Completed at 5 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-10.

Sponsored by University Health Network, Toronto · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a pilot, prospective, randomized controlled trial of a novel sleep health program versus no sleep intervention in chronic pain patients. The Sleep Health program will consist of weekly home-based videos and digital materials termed "Self-Management for Sleep Care", which will provide participants with information on how to improve their sleep through education on sleep hygiene, relaxation training, and cognitive behavioural components. Patients will be also be screened through undiagnosed sleep apnea. For those determined to have suspected undiagnosed moderate or severe sleep apnea, they will be receive a recommendation for referral to a sleep clinic as part of standard of care. The study aims to evaluate the feasibility and effectiveness of the Sleep Health Program which includes the videos and digital materials and screening for sleep apnea in patients with chronic pain.

Read the detailed description

All participants will complete sleep, pain, and functional questionnaires. Additionally, all participants will undergo one overnight oximetry reading using the wristwatch pulse oximetry. Following these baseline assessments and questionnaires, participants will be randomized to either the control group or the Sleep Health Program.

A)Sleep Health Program Group Participants in this group will receive usual care from their pain physician. Participants will also receive the Self-Management for Sleep Care videos and digital materials. Participants with suspected moderate/severe sleep apnea as determined by oximetry, but who have not been diagnosed with sleep apnea prior to the study, will be recommended for referral to a sleep clinic as part of standard of care.

B)Control Group Participants in this group will receive usual care from their pain physician.

First follow up visit:

At 8 weeks after the initial visit, all participants will attend their first follow-up visit and complete the sleep, pain and functional questionnaires and 7-day sleep diary recording, and report any changes in medications.

Second follow up visit:

At 6 months after the initial visit, all participants will attend their second follow-up visit and complete the sleep, pain and functional questionnaires, 7-day sleep diary recording and report any changes in medications. Control participants will receive information provided by the Self-Management for Sleep Care program. Control participants with suspected undiagnosed moderate/severe sleep apnea will be recommended for referral to a sleep clinic as part of standard of care.

02

Conditions studied

  • Sleep Disordered Breathing
  • Chronic Pain
  • Sleep
03

In context

Sleep Apnea Syndromes

2,162 studies on the registry are indexed under Sleep Apnea Syndromes; 290 are open to participants now.

This study's enrollment of 40 is below the median of 53 across 1,386 interventional studies indexed under Sleep Apnea Syndromes.

Browse Sleep Apnea Syndromes studies →

Lead sponsor

University Health Network, Toronto is the lead sponsor of 1,411 studies on the registry; 292 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 3 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

The inclusion criteria are:

  • Adult patients (≥18 years old) with cognitive capability
  • Diagnosed with chronic non-cancer pain for > 3 months
  • Reports sleep disturbances such as difficulty falling asleep, staying asleep, or problems waking up too early (responds "Mild", "Moderate", "Severe", or "Very Severe" to items 1, 2, or 3 on the Insomnia Severity Index).

Exclusion criteria

Exclusion Criteria:

  • Patients with chronic pain secondary to a neoplasm or metastasis
  • Conditions potentially interfering with comprehension and delivery of informed consent, such as certain neurological or psychiatric disorders
  • Patients with severe insomnia (Insomnia Severity Index ≥ 22)
  • Restless legs syndrome
  • Periodic limb movement disorder
  • Sleep apnea
  • Narcolepsy
  • Seizure disorder
  • Patients who are pregnant
  • Currently undergoing a psychological treatment for insomnia
  • Participants who require an urgent sleep physician referral (within four weeks) due to serious medical conditions or safety critical-occupations according to the 2011 Canadian Thoracic Society (CTS) guidelines (e.g. unstable ischemic heart disease, recent cerebrovascular disease, congestive heart failure, refractory systemic hypertension, pulmonary hypertension, hypercapnia respiratory failure).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • No intervention
    Control Group

    Participants randomized to the Control Group will receive usual care from their pain physician.

  • Experimental
    Sleep Health Program - Suspected No/mild sleep apnea

    Participants randomized to the Sleep Health Program with no/mild sleep apnea.

    Behavioral: Sleep Health Program for Participants with No/Mild Sleep Apnea

  • Experimental
    Sleep Health Program - Suspected Moderate/severe sleep apnea

    Participants randomized to the Sleep Health Program with suspected moderate/severe sleep apnea.

    Behavioral: Sleep Health Program for Participants with Moderate/Severe Sleep Apnea

Interventions

  • BehavioralSleep Health Program for Participants with No/Mild Sleep Apnea

    Participants randomized to the Sleep Health Program will receive the Self-Management for Sleep Care videos and digital materials.

    Also known as: Sleep Health group

  • BehavioralSleep Health Program for Participants with Moderate/Severe Sleep Apnea

    Participants randomized to the Sleep Health Program with suspected moderate/severe sleep apnea will receive the Self-Management for Sleep Care videos and digital materials, and be recommended for referral to a sleep clinic as part of standard of care.

    Also known as: Sleep Health group

06

What researchers measure

Primary outcomes

  1. Feasibility of Sleep Health Program

    Proportion of participants at baseline, and who completed the follow-up visits at 8 weeks.

    Time frame: 8 weeks

  2. Feasibility of Sleep Health Program

    Proportion of participants at baseline, and who completed the follow-up visits at 6 months.

    Time frame: 6 months

Secondary outcomes

  1. Efficacy of Sleep Health Program on Functional Outcomes of Sleep Questionnaire-10.

    Change from baseline in sleep scores on the Functional Outcomes of Sleep-10 questionnaire at 8 weeks and 6 months. Score range: 0-40, lower score indicates worse functional outcomes.

    Time frame: 6 months

  2. Efficacy of Sleep Health Program on Insomnia Severity Index

    Change from baseline in Insomnia Severity Index score at 8 weeks and 6 months. Score range: 0-28, higher score indicates greater insomnia severity.

    Time frame: 6 months

07

Study locations

5 sites
  • St. Michael's Hospital
    Toronto, Ontario M5B 1W8, Canada
  • Toronto Rehab Institute (TRI)
    Toronto, Ontario M5G 2A2, Canada
  • Women's College hospital
    Toronto, Ontario M5S 1B2, Canada
  • Toronto Western Hopsital, Pain Clinic, Dept. of Anesthesia
    Toronto, Ontario M5T2S8, Canada
  • Mount Sinai Hospital, Department of Anesthesia
    Toronto, Ontario, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04299100
Lead sponsor
University Health Network, Toronto
Collaborators
MOUNT SINAI HOSPITAL, Unity Health Toronto, Women's College Hospital
Responsible party
Dr. Frances Chung (Professor, University of Toronto, University Health Network, Toronto) — Principal investigator
First posted
Mar 6, 2020
Start date
Jul 9, 2020
Primary completion
Sep 28, 2021
Completion
Sep 28, 2021
Last update
Dec 10, 2021

Study contacts

Frances Chung, MBBS FRCPC
principal investigator · UHN/ University Health Network

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion